Richard Haupt, MD, MPH, discusses the different pharmaceutical companies’ efforts to develop a C. difficile vaccine.
Richard Haupt, MD, MPH, vice president of Medical Development at Pfizer Vaccines, discusses the different pharmaceutical companies’ efforts to develop a C. difficile vaccine.
Interview Transcript (modified slightly for readability):
“Are there other companies that are developing C. difficile vaccine? Yes, there are. Another major pharmaceutical vaccine maker Sanofi Pasteur is also in a phase 3 trial to assess the safety and efficacy of vaccines. And so, we, and Sanofi, are both trying to do the same thing, taking the same approach. The vaccine might be a little bit different but they’re both vaccines that are targeted against the toxins that mediate the disease.”
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.